The occurrence of ATLL in a patient with HAM is extremely uncommon and has been described in only three other patients. 4 6 It has been shown that the viruses isolated from patients with HAM and ATLL are identical in their genomic composition. The HTLV 1 carrier rate has been estimated to be 15% in the general population in Japan, and 5% in the Caribbean. The lifetime risk of developing ATLL if infected with HTLV 1 is 2% to 5% with an interval of about 30 years between acquiring the infection and developing symptoms. On the other hand the lifetime risk of developing HAM/TSP has been estimated to be 0-25%. Familial clustering of both ATLL and HAM is well recognised but the occurrence of both the conditions in the same family is extremely uncommon 
